(Q45268799)

11 December 2017

Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival (English)

1 reference

11 December 2017

1 reference

Tokujiro Yano

1

1 reference

11 December 2017

Naoko Miura

2

1 reference

11 December 2017

Tomoyoshi Takenaka

3

1 reference

11 December 2017

Akira Haro

4

1 reference

11 December 2017

Hiroshi Okazaki

5

1 reference

11 December 2017

Taro Ohba

6

1 reference

11 December 2017

Hidenori Kouso

7

1 reference

11 December 2017

Takuro Kometani

8

1 reference

11 December 2017

Fumihiro Shoji

9

1 reference

11 December 2017

Yoshihiko Maehara

10

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

11 December 2017

1 reference

11 December 2017

113

1 reference

11 December 2017

5

1 reference

11 December 2017

1012-1018

1 reference

Worldwide epidemiological patterns of lung cancer in nonsmokers

11 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Survival in operable non-small-cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Smoking and lung cancer survival: the role of comorbidity and treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Prognostic value of smoking status in operated non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Lung cancer incidence in never smokers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Incidence of lung cancer in a large cohort of non-smoking men from Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Longer survival after resection of non-small cell lung cancer in Japanese women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Sex-associated differences in survival of patients undergoing resection for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23679

7 January 2021

Identifiers

DOI

10.1002/CNCR.23679

1 reference

11 December 2017

1 reference